Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
Portfolio Pulse from Vandana Singh
Pfizer Inc plans to reduce its stake in Haleon Plc to about 24%, selling approximately 630 million shares valued at £2 billion. This follows Pfizer's strategy to divest its ownership in Haleon, a company known for brands like Sensodyne, which emerged from a merger between Pfizer's and GSK Plc's consumer healthcare divisions in 2019. Haleon intends to buy back £500 million of shares in 2024 and repurchase about £315 million of shares from Pfizer off-market. GSK has also been reducing its stake in Haleon, with its latest sale in January bringing its ownership down to 4.2%.
March 18, 2024 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GSK Plc has been progressively reducing its stake in Haleon since its inception, with the latest sale in January reducing its ownership to 4.2%, potentially impacting investor perception and stock price.
GSK's ongoing divestment from Haleon, including the recent sale reducing its stake to 4.2%, reflects a strategic shift that could have a neutral short-term impact on its stock as investors reassess its investment portfolio.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Pfizer Inc plans to sell approximately 630 million shares of Haleon Plc, reducing its stake to about 24% and potentially impacting its financial position and investor perception.
Pfizer's decision to reduce its stake in Haleon is part of its strategic divestment, which could lead to a neutral short-term impact on its stock as the market absorbs the news and evaluates its financial implications.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Haleon Plc, known for brands like Sensodyne, plans to buy back £500 million of shares in 2024 and repurchase about £315 million of shares from Pfizer, potentially affecting its stock price.
Haleon's announcement of a significant share buyback program and the repurchase of shares from Pfizer indicate a positive outlook on its own stock, likely leading to a positive short-term impact on its share price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 95